Mechanistically, CS055 induces DNA double-strand break and alters the balance of pro-apoptotic vs. antiapoptotic Bcl-2 proteins, by which CS055 interacts with ABT-199 to overcome the acquired resistance to ABT-199 in AML without significantly increasing systemic toxicity. The gene discussed is BCL2; the disease is acute myeloid leukemia.